EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors

Author: de Wit R.   Pawinsky A.   Stoter G.   van Oosterom A.T.   Fossa S.D.   Paridaens R.   Svedberg A.   de Mulder P.H.M.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.33, Iss.3, 1997-03, pp. : 493-495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content